Reaction
Foetal Heart Rate Deceleration Abnormality reporting signals
As of the last recalculation, Foetal Heart Rate Deceleration Abnormality appears in 694 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 62.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 19 | 62.7 | 62.8 |
| Misoprostol | 18 | 56.9 | 57.0 |
| Dalteparin Sodium | 18 | 52.4 | 52.5 |
| Magnesium Sulfate Heptahydrate | 21 | 49.8 | 49.9 |
| Magnesium Sulfate In Water For | 20 | 48.3 | 48.4 |
| Magnesium Sulfate | 20 | 47.3 | 47.4 |
| Labetalol | 18 | 41.6 | 41.6 |
| Ampicillin | 8 | 29.3 | 29.3 |
| Ampicillin Sodium | 8 | 29.3 | 29.3 |
| Sevoflurane | 6 | 21.8 | 21.8 |
| Ceftriaxone Sodium | 24 | 19.4 | 19.4 |
| Ceftriaxone | 19 | 17.8 | 17.8 |
| Propofol | 20 | 16.9 | 16.9 |
| Remdesivir | 5 | 11.3 | 11.3 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 5 | 8.3 | 8.3 |
| Rimegepant Sulfate | 3 | 7.1 | 7.1 |
| Cinacalcet Hydrochloride | 6 | 3.9 | 3.9 |